Metal impurities in food and drugs

Pharmaceutical Research

Volumn 27, Issue 5, 2010, Pages 750-755

  Abernethy, Darrell R ^a   DeStefano, Anthony J ^a   Cecil, Todd L ^a   Zaidi, Kahkashan ^a   Williams, Roger L ^a  

^a UNITED STATES PHARMACOPEIA   (United States)

Author keywords

Analysis; Impurities; Limits; Metals; Standards; Us pharmacopeia

Indexed keywords

ARSENIC; CADMIUM; CHROMIUM; COPPER; COPPER SULFATE; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; GOLD; HYPERICUM PERFORATUM EXTRACT; IRIDIUM; LEAD; MANGANESE; MERCURY; METAL; MINERAL; MOLYBDENUM; MULTIVITAMIN; NATURAL PRODUCT; NICKEL; OSMIUM; PALLADIUM; PLATINUM; RHODIUM; RUTHENIUM; SELENIUM; UNINDEXED DRUG; VANADIUM; VITAMIN; ZINC;

CADMIUM POISONING; DIET SUPPLEMENTATION; DRUG CONTAMINATION; DRUG IMPURITY; DRUG SAFETY; DRUG SCREENING; ENVIRONMENTAL HEALTH; FOOD ANALYSIS; FOOD CONTAMINATION; GOOD MANUFACTURING PRACTICE; HEALTH HAZARD; HUMAN; INTOXICATION; LEAD POISONING; MERCURIALISM; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; STANDARDIZATION; TOXICOKINETICS;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG CONTAMINATION; FOOD ANALYSIS; FOOD CONTAMINATION; HUMANS; METALS; PHARMACOPOEIAS AS TOPIC; THRESHOLD LIMIT VALUES;

EID: 77953286307     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0080-3     Document Type: Note

References (48)

1. International Conference on Harmonization. Q3 quality guidelines. 2006. http://www.ich.org/cache/compo/276-254-1.html (accessed June 22, 2009).
2. USP. Heavy metals testing methodologies workshop (August 2627, 2008) summary. 2008. www.usp.org/pdf/EN/hottopics/2008MetalsWorkshopSummary.pdf (accessed June 22, 2009).
3. USP. Pharmacopoeia of the United States of America. Boston: Wells and Lilly; 1820.
4. Gilman A, Goodman L. The pharmacological basis of therapeutics. 1st ed. New York: Macmillan; 1941.
5. . FDA. Orange book: approved drug products with therapeutic equivalence. 2009. www.accessdata.fda.gov/scripts/cder/ob/ default.cfm (accessed June 22, 2009).
6. EMEA. Guideline on the specification, limits for residues of metal catalysts. 2008. www.emea.europa.eu/pdfs/human/swp/ 444600enfin.pdf (accessed June 11, 2009).
7. Canfield RL, Henderson CR, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10 μg per deciliter. N Engl J Med. 2003;348:1517-1526
8. Bakir F, Damluji SF, Amin-Zaki L, et al. Methyl mercury poisoning in Iraq. Science. 1973;181:230-241
9. Marsh DO. Dose-response relationships in humans: methyl mercury epidemics in Japan and Iraq. In: Eccles CU, Annau Z, editors. The toxicity of methyl mercury. Baltimore: John Hopkins University Press; 1987.
10. EPA. Inorganic mercury. Integrated risk information system. Washington: EPA; 1985.
11. EPA. Cadmium. Integrated, risk information system. Washington: EPA; 1995.
12. ATSDR. Toxicological profile for lead. Atlanta: ATSDR; 2007.
13. Hong F, Jin T, Zhang A. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population. BioMetals. 2004; 17:573-580 (Pubitemid 41214272)
14. Madden EF, Fowler BA. Mechanisms of nephrotoxicity from metal combinations: a review. Drug Chem Toxicol. 2000; 23:1-12.
15. Ekong EB, Jaar BG, Weaver VM. Lead-related nephrotoxicity: a review of the epidemiologic evidence. Kidney Int. 2006;70:2074-2084 (Pubitemid 44871369)
16. Åkesson A, Lundh T, Vahter M, et al. Tubular and glomerular kidney effects in Swedish, women with low environmental cadmium exposure. Environ Health Perspect. 2005; 113(11):1627-1631 (Pubitemid 41614922)
17. Buchet JP, Lauwerys R, Roels H, et al, Renal effects of cadmium body burden, of the general population. Lancet. 1990;336:699-702.
18. Saper RB, Kales SN, Paquin J, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA. 2004;292(23):2868-2873 (Pubitemid 39628234)
19. Honary S, Ebrahimi P, Naghibi F, Mosaddegh M, Shahhoseini S. Study on the simultaneous determination of Pb and Cd in some commercial medicinal plants by both atomic absorption and voltametry methods. Anal Lett 2007;40:2405-2414 (Pubitemid 350034555)
20. Caldas ED, Machado LL. Cadmium, mercury, and lead in medicinal herbs in Brazil. Food Chem Toxicol. 2004;42:599-603.
21. Rose M, Lewis J, Langford N, et al. Arsenic in seaweed-forms, concentration, and dietary exposure. Food Chem Toxicol. 2007; 45:1263-1267 (Pubitemid 46621095)
22. Kauffman JF, Westenberger BJ, Robertson. JD, Guthrie J, Jacobs A, Cummins SK. Lead in pharmaceutical products and dietary supplements. Regul Toxicol Pharmacol. 2007;48(2):128-134 (Pubitemid 46818662)
23. Turck M. Metals in active pharmaceutical ingredients and excipients. Presentation to Institute of Medicine of the National Academy of Sciences of the United States, Washington, DC, USP Heavy Metals Testing Methodologies Workshop, August 26,2008.
24. Yokel RA, Lasley SM, Dorman DC. The speciation of metals in. mammals influences their toxicokinetics and toxicodynamics and therefore human health risk assessment. (Critical Review) J Toxicol Environ Health B. 2006;9:63-85.
25. Sharma VK, Sohn M. Aquatic arsenic: toxicity, speciation, transformations, and remediation. Environ Int. 2009;35:743-759
26. Losi ME, Amrhein C, Frankenberger WT. Environmental biochemistry of chromium. Rev Environ Contam Toxicol. 1994; 136:91-121.
27. Akter KF, Owens G, Davey DE, Naidu R. Arsenic speciation and toxicity in biological systems. Rev Environ Contam Toxicol. 2005;184:97-149.
28. Scelfo GM, Flegal AR. Lead in calcium supplements. Environ Health Perspect. 2000;108:309-319
29. Kauffman JF, Westenberger BJ, Robertson JD, Guthrie J, Jacobs A, Cummins SK. Lead in pharmaceutical products and dietary supplements. Regul Toxicol Pharmacol. 2007;48(2):128-134 (Pubitemid 46818662)
30. Mindak WR, Cheng J, Canas BJ, Bolger PM. Lead in women's and children's vitamins. J Agric Food Chem. 2008; 56(16):6892-6896
31. Waxman HA. Letter to FDA regarding Vitamin Shoppe Multivitamins Especially for Women. April 4,2007. http://oversight.house. gov/documents/ 20070409120002.pdf (accessed September 15, 2009).
32. Dolan SP, Nortrup DA, Bolger PM, Capar SG. Analysis of dietary supplements for arsenic, cadmium, mercury, and lead using inductively coupled, plasma-mass spectrometry. J Agric Food Chem. 2003; 51(5):1307-1312
33. Carbonell-Barrachina AA, Garcia E, Sánchez Soriano J, Aracil P, Burló F. Effects of raw materials, ingredients, and production lines on arsenic and copper concentrations in confectionery products. J Agric Food Chem. 2002;50(13):3738-3742 (Pubitemid 34640699)
34. Raman P, Patino LC, Nair MG. Evaluation of metal and. microbial contamination in botanical supplements. J Agric Food Chem. 2004;52(26):7822-7827 (Pubitemid 40063590)
35. Komaromy-Hiller G, Ash KO, Costa R, Howerton K. Comparison of representative ranges based on US patient population and literature reference intervals for urinary trace elements. Clin Chim Acta. 2000;296:71-90. (Pubitemid 30243141)
36. Paschal DC, Ting BG, Morrow JC, et al. Trace metals in urine of United States residents: reference range concentrations. Environ Res. 1998;76:53-59
37. IARC. Arsenic in drinking-water. 2004. http://monographs.iarc. fr/ENG/Monographs/vol84/mono84-6A.pdf (accessed July 16, 2009).
38. EPA. Integrated risk information system (IRIS) on arsenic. 1999. http://www.epa.gov/iris/subst/0278.htm (accessed December 02, 2009).
39. ATSDR. Toxicological profile for cadmium (Draft for Public Comment). Atlanta: ATSDR; 2008.
40. USP. Pharmacopoeia of the United. States of America, Procedure 121, Time-limit test for heavy metals. 8th Revision. Philadelphia: Lippincott; 1905.
41. USP. Pharmacopoeia of the United States of America, Heavy metals test. 12th Revision. Easton, PA: Mack Printing; 1942.
42. USP. USP 32-NF 27, Heavy Metals <231>. Rockville, MD: USP; 2009.
43. European Directorate for the Quality of Medicines and HealthCare. European pharmacopoeia, Chapter 2.4.8, Heavy metals. 6th ed. Strasbourg: EMEA; 2009.
44. Ministry of Health, Labour, and Welfare. Japanese pharmacopoeia, Chapter 1.07, Heavy metals limit test. 1.5th ed. Tokyo: MHLW; 2001.
45. WHO. International pharmacopoeia, Chapter 2.2.3, Limit test for heavy metals. 4th ed. Geneva: WHO; 2006.
46. Blake KB. Harmonization of the USP, EP, and JP heavy metals testing procedures. Pharm Forum. 1995;21:1632-1637
47. Lewen N, Mathew S, Schenkenberger M, Raglione T. A rapid ICP-MS screen for heavy metals in pharmaceutical compounds. J Pharm Biomed Anal. 2004;35:739-752 PMID: 15193718. (Pubitemid 38757664)
48. Wang T, Wu J, Hartman. R, Jia X, Egan RS. A multi-element ICP-MS survey method as an alternative to the heavy metals limit test for pharmaceutical materials. J Pharm Biomed Anal. 2000;23:867-890